Exploratory Study of OPC-12759 Ophthalmic Suspension

Keratoconjunctival Epithelial Disorder Clinical Trial

Official title: Exploratory Study of OPC-12759 Ophthalmic Suspension in Patients With Keratoconjunctiva Epithelial Disorder

Status Completed

Clinical Trial Summary

The purpose of this study is to evaluate the efficacy of OPC-12759 ophthalmic suspension for patients with keratoconjunctival epithelial disorder compared with sodium hyaluronate. Also, safety of OPC-12759 is to be assessed.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Keratoconjunctival Epithelial Disorder

• NCT number: NCT01493180
• Study type: Interventional
• Source: Otsuka Pharmaceutical Co., Ltd.
• Status: Completed
• Phase: Phase 2
• Start date: December 2011
• Completion date: December 2012